A randomized controlled trial of nitrate supplementation in well-trained middle and older-aged adults

PLoS One. 2020 Jun 23;15(6):e0235047. doi: 10.1371/journal.pone.0235047. eCollection 2020.

Abstract

Purpose: Nitrate (NO3-), through its conversion to nitrite (NO2-) and nitric oxide, has been shown to increase exercise tolerance in healthy younger adults and older diseased patients. Nitrate's effect in well-trained middle to older-aged adults has not been studied. Therefore, the purpose of this investigation was to examine the effects of a NO3- rich beverage on submaximal constant work rate exercise time in well-trained middle to older-aged adults.

Methods: This was a randomized controlled cross-over trial with 15 well-trained middle to older-aged adults, 41-64 year-old, who received one of two treatments (NO3- rich beverage then placebo or placebo then NO3- rich beverage), after which an exercise test at 75 percent of the subject's maximal work rate was completed.

Results: The NO3- rich beverage increased plasma NO3- and NO2- levels by 260 μM and 0.47 μM, respectively (p<0.001). Exercise time was not significantly different (p = 0.31) between the NO3- rich versus placebo conditions (1130±151 vs 1060±132 sec, respectively). Changes in exercise time between the two conditions ranged from a 55% improvement to a 40% decrease with the NO3- rich beverage. Oxygen consumption and rating of perceived exertion were not significantly different between the two conditions.

Conclusion: In middle to older-aged well-trained adults, NO3- supplementation has non-significant, albeit highly variable, effects on exercise tolerance. ClinicalTrials.gov Identifier: NCT03371966.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Beverages*
  • Blood Pressure / physiology
  • Cross-Over Studies
  • Dietary Supplements*
  • Exercise / physiology*
  • Exercise Test
  • Exercise Tolerance / physiology*
  • Female
  • Heart Rate / physiology
  • Humans
  • Male
  • Middle Aged
  • Nitrates / administration & dosage*
  • Nitrates / blood
  • Nitrites / blood
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / statistics & numerical data
  • Oxygen Consumption / physiology

Substances

  • Nitrates
  • Nitrites

Associated data

  • ClinicalTrials.gov/NCT03371966

Grants and funding

Funding: This work was supported by a grant from Isagenix International LLC, Gilbert, AZ awarded to MJB. The funding source had no involvement with the study design, data collection, data analysis and interpretation or the decision to submit this work for publication.